EP2552445 - Bibliographic data

ANTAGONISTS DU RECEPTEUR OPIOID (NALTREXONE) POUR L'UTILISATION DANS LE TRAITEMENT DES MALADIES DU HERPES ZOSTER

Last update	06/06/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	IMUNEKS FARMA ILAÇ SANAYI VE TICARET A.S. Pak is Merkezi Prof. Dr. Bülent Tarcan Sok. No: 5/1 Gayrettepe 34349 Istanbul Turquie
(72) Inventors	Ibrahim Mustafa Iskender PISAK Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1 Gayrettepe / Istanbul 34349 Turquie Mehmet PISAK Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1 Gayrettepe / Istanbul 34349 Turquie Mehmet Levent SELAMOGLU Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1 Gayrettepe / Istanbul 34349 Turquie Semra BINGOL Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1 Gayrettepe / Istanbul 34349 Turquie
(74) Agent	Mail recipient Coral, Nükhet Serra Yardimci Deris Patent ve Marka Acentaligi A.S. Inebolu Sokak, No: 5 Deris Patent Binasi Kabatas/Setüstü 34427 Istanbul Turquie

(21) Request number	EP11720347.1
(22) Request date	31/03/2011

(11) Publication number	EP2552445
Publication date	24/01/2018

(54) Title of the invention	ANTAGONISTS DU RECEPTEUR OPIOID (NALTREXONE) POUR L'UTILISATION DANS LE TRAITEMENT DES MALADIES DU HERPES ZOSTER
(51) International classification	A61K 31/485, A61K 9/00, A61K 9/06, A61K 9/48, A61K 47/32, A61K 47/44, A61P 31/22
International classification (before reform)	None

Claimed priority	(31) Number: 201002473 (32) Date: 31/03/2010 (33) Country: TR
Initial application	None
Divisional application	None

Expected annuity	Annuity: 8 - Amount: 135 € - Due date 03/04/2018 Surtax: 8 - Amount: 27 € - Due date 04/10/2018
Last annuity	None

Publication	None
History	Publication de la délivrance du brevet européen - Legal date 24/01/2018 Entrée en période de grâce du brevet d'invention - Legal date 04/04/2018 Déchéance du brevet d'invention après période de grâce - Legal date 03/04/2018